Life Sciences Partners in €17.5m Immunic series-A

Other investors included Bayern Kapital and High-Tech Gründerfonds, as well as other unnamed backers.

The funding will enable the company to invest in product development.

Amsterdam-based LSP, which focuses on biotech startups, held a final close for its fifth fund on $280m in June this year.

LifeCare is a Switzerland-based investor providing private equity and mezzanine financing to life sciences and healthcare companies.

Company
Founded in 2016 and based in Planegg-Martinsried, Immunic develops medicine for the treatment of immune and autoimmune diseases, such as inflammatory bowel disease or psoriasis.

People
Life Sciences Partners – Jörg Neermann (partner).
Immunic – Manfred Gröppel (co-founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• Germany
• Venture
• High-Tech Gründerfonds
• Life Science Partners